. . . . . . . . . . . . "a(SCHEM:Sirolimus) -| bp(GOBP:\"cell proliferation\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "mTOR inhibitor rapamycin, which inhibits VSMC proliferation, is in effective use in clinic and is applied on stents for preventing restenosis [146, 147, 151]." . . "Selventa" . . . . "2014-07-03T14:33:32.078+02:00"^^ . . .